Sirtris in-Licenses Genetic Agent From Robarts Research Institute
Posted on: Wednesday, 12 March 2008, 09:01 CDT
Sirtris Pharmaceuticals has obtained exclusive, worldwide rights from Robarts Research Institute for NamPRT, an important genetic driver of cellular stress resistance and longevity in mammals.
In research relating to atherosclerosis and cellular aging, researchers showed that the introduction of the NamPRT gene into aging human vascular smooth muscle cells delayed their deterioration and substantially lengthened cell lifespan.
Karl Normington, senior director of intellectual property and licensing at Sirtris, said: "In-licensing the exclusive rights to these patents is part of our overall strategy to build the broadest platform of technology and intellectual property for the development of sirtuin therapeutics for the treatment of diseases of aging."
Source: Datamonitor
Related Articles
- 2006 Joint Conference to Examine Ways to 'Invest in Aging'
- Frailty and the Aging Male
- Decline of Serum Levels of Free Testosterone in Aging Healthy Chinese Men
- Testosterone Supplementation in the Aging Male: Which Questions Have Been Answered?
- Joint Conference Examines the Changing Face of Aging
- Giving Justice to Aging: Geriatric Jurisprudence in America
- Aged By Age-and Culture, Too
- Aged By Culture Author 'Faces' Children's Images of Aging
- The Philippine Male Aging Survey
- Report on the 4th World Congress on the Aging Male
 |
 |
User Comments (0)
RSS Feeds